Intchains Group
ICG
Mawson Infrastructure
MIGI
Ebang International
EBON
Argo Blockchain
ARBK
Hive Blockchain
HIVE
US Stock MarketDetailed Quotes
NMRA Neumora Therapeutics
- 1.970
- -8.630-81.42%
Close Jan 2 16:00 ET
- 2.050
- +0.080+4.06%
Post 19:04 ET
318.28MMarket Cap1.77P/E (TTM)
2.250High1.830Low44.69MVolume1.880Open10.600Pre Close90.06MTurnover52.63%Turnover RatioLossP/E (Static)161.56MShares21.00052wk High0.99P/B167.29MFloat Cap1.83052wk Low--Dividend TTM84.92MShs Float21.000Historical High--Div YieldTTM3.96%Amplitude1.830Historical Low2.015Avg Price1Lot Size
About Neumora Therapeutics Company
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Company Profile
SymbolNMRA
Company NameNeumora Therapeutics
Listing DateSep 15, 2023
Issue Price17.00
Founded2019
CEOMr. Henry O. Gosebruch
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 200
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Websitehttp://www.neumoratx.com
Company Executives
- Name
- Position
- Salary
- Henry O. Gosebruch
- Director, President and Chief Executive Officer
- 22.00M
- Dr. Daljit Singh Aurora, Pharm.D.
- Chief Strategy Officer
- --
- Jason G. Duncan
- Chief Legal Officer
- 4.12M
- Dr. Joshua Pinto, PhD
- Chief Financial Officer
- --
- Carol Suh
- Chief Operating Officer
- --
- Michael Lee Milligan
- Principal Accounting Officer
- --
- Paul L. Berns
- Executive Chairman of the Board
- 8.57M
- Kristina M. Burow
- Independent Director
- 686.60K
- Alaa Halawa
- Independent Director
- 671.20K
- Dr. Maykin Ho, PhD
- Independent Director
- 430.97K
- David Piacquad
- Independent Director
- 620.76K
- Matthew K. Fust
- Independent Director
- 485.53K
- Dr. Robert Lenz, M.D.
- Head of Research and Development
- 13.58M
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.